Development of Clinical Prediction Score for Chemotherapy Response in Advanced Non-Small Cell Lung Cancer Patients

The outcomes of advanced non-small cell lung cancer (NSCLC) patients have been significantly improved with novel therapies, such as tyrosine kinase inhibitors and immune checkpoint inhibitors. However, in resource-limited countries, platinum-doublet chemotherapy is mainly used as a first-line treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Chayangsu, Chawalit, Khorana, Jiraporn, Charoentum, Chaiyut, Sriuranpong, Virote, Patumanond, Jayanton, Tantraworasin, Apichat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914574/
https://www.ncbi.nlm.nih.gov/pubmed/36766868
http://dx.doi.org/10.3390/healthcare11030293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914574/
https://www.ncbi.nlm.nih.gov/pubmed/36766868
http://dx.doi.org/10.3390/healthcare11030293

Ejemplares similares